Aevum Digital
AYUSH Quality Management

Ayush QMS Schedule T Quality Management Software for AYUSH Manufacturers

A quality management system for Indian Ayurveda, Siddha and Unani drug manufacturers that digitises GMP records from raw-herb receipt through batch release and export documentation.

Batch Record Sneha Paka stageYield reconciled E-signature
12Kalpana dosage forms with batch record templates
214API monographs in the reference data set
125Schedule T and WHO-GMP clauses mapped to records
31 Jul 2029Date for existing units to align with revised Schedule T2

Solution Overview

Ayush QMS is a quality management system built for Indian Ayurveda, Siddha and Unani drug manufacturers. It replaces the paper ledgers, batch manufacturing records and spreadsheets commonly used to meet Schedule T of the Drugs Rules, the good manufacturing practice (GMP) standard for these medicines.

The data model reflects Ayurvedic manufacturing directly. Batch records are specific to each of 12 kalpana dosage forms, Rasa Shastra purification (Shodhana) and Bhasma preparation are recorded with electronic signatures, and quality control specifications are derived from seeded Ayurvedic Pharmacopoeia (API) monographs and Ayurvedic Formulary (AFI) references.

Batch Record: Sneha PakaIllustrative, sample data
StageParameterResult
Line clearanceArea and equipmentVerified
Kwatha preparationVolume and temperatureRecorded
Sneha PakaStage end pointIn progress
Yield reconciliationVariance against limitPending
BN-2047Batch number
4 of 7Stages complete
Approved lotResult
Herb lot HL-310QC approved
Oil lot OL-118QC approved
Figure 1. Kalpana Batch Record. Illustrative screen of an electronic batch record, showing stage status and the approved lots allocated to the batch. All values are sample data.

Quality Challenges Addressed

India had 8,604 licensed AYUSH drug manufacturing units in April 2024, of which 7,347 make Ayurvedic medicines1. The Drugs (Eleventh Amendment) Rules, 2026 revised Schedule T and extended the requirements for manufacturing, quality and documentation, with existing manufacturers given until 31 July 2029 to align2,3. Overseas buyers and regulators also expect documented, auditable records.

Records That Fail Data Integrity Tests

Paper batch records completed after the event breach the ALCOA+ principle that entries are contemporaneous and attributable. Corrections, missing signatures and back-filled yields are common findings.

Material and Batch Control by Hand

Quarantine labels can fall off, specifications are copied from pharmacopoeia volumes into spreadsheets, and a recall requires manual reconstruction of which herb lots went into which batches.

Generic Software Does Not Fit

General pharmaceutical quality software typically has no model of processes such as Sneha Paka or Asava fermentation, and no Rasa Shastra controls or API monograph content.

How Ayush QMS Works

The sequence below follows a batch from supplier qualification to release and distribution. Each step writes to the audit trail, and status gates prevent a step from starting until the previous step is complete.

  1. Qualify Supplier

    GACP audit and staged pipeline

  2. Receive Herbs

    Lot quarantined; CITES check

  3. Test Raw Material

    Monograph specifications and HPTLC

  4. Release Lot

    Quarantine to approved

    Planned
  5. Create Batch

    Formula and kalpana template

  6. Allocate Lots

    Approved lots only, traced

  7. Execute Batch Record

    Kalpana stages and Shodhana

  8. Reconcile Yield

    Variance raises a deviation

  9. Submit for QC

    Blocked by open deviations

  10. Finished-Product QC

    OOS quarantines the batch

  11. QA Disposition

    E-signature and four-eyes check

  12. CoA and Distribution

    Forward trace for recalls

Step in the platformDistinctive stepHuman decisionPlanned capability
Figure 2. Raw Herb to Batch Release. The twelve-step batch path. Step 7 records kalpana-specific stages, and Shodhana and Bhasma steps with electronic signature where the formula requires them. Automated release of raw-material lots in step 4 is planned.
  1. Approved suppliers deliver
  2. Approved lots allocated
  3. Open yield deviations block QC
  4. QA disposition with e-signature
Figure 3. Status Gates. Controls that hold the batch until each condition is met.

Platform Modules

Compliance Foundation

  • Tenant isolation
  • Verifiable audit trail
  • E-signatures
  • Role-based access
  • Workflow engine
  • Retention controls

AYUSH Knowledge and Batch Records

  • API monographs
  • AFI formulary
  • Pratinidhi dravya
  • Harvest calendar
  • Formula master
  • Kalpana stage records
  • Rasa Shastra
  • Batch disposition

Quality Control and Quality System

  • QC tests and OOS
  • CoA generation
  • Method validation
  • Stability studies
  • Deviations and CAPA
  • Training
  • Internal audits
  • Equipment
  • Complaints and recalls
  • Label compliance

Supply Chain, Regulatory and Export

  • Supplier pipeline
  • GACP audit scoring
  • CITES lot guard
  • Lot traceability
  • Schedule T mapping
  • Ayush Mark checklist
  • Export dossiers
  • Regulatory feed
Figure 4. Platform Module Map. Current modules of Ayush QMS grouped by layer, from the compliance foundation to quality, regulatory and export functions.

AYUSH Knowledge Base

Reference content is held in the platform so that acceptance criteria are derived from monographs in place of being copied into spreadsheets. The figures below describe the current reference data set.

API monographs214
Marker compounds232
HPTLC fingerprints62
AFI formulations150
GMP clauses125
Figure 5. Reference Data Set. Number of records by reference type, including Schedule T and WHO-GMP clauses used for gap analysis.

Key Capabilities

Electronic Batch Records

  • Versioned formula master and templates for 12 kalpana types
  • Line clearance and in-process parameters
  • Sneha Paka, Avaleha Paka, fermentation, sieving, compression and distillation stages
  • Yield reconciliation with automatic deviation

Rasa Shastra

  • Shodhana records with electronic signature
  • Sign-off by an authorised Vaidya or Hakim
  • Bhasma preparation logs and puta cycles
  • Bhasma quality tests

Quality Control

  • Test requests with server-side OOS detection
  • Phase I and II OOS investigations
  • Certificates of analysis and method validation
  • Stability studies, retain samples and analyst competency gate

Quality System

  • Deviations and CAPA
  • Training records and internal audits
  • Equipment calibration and qualification
  • Complaints, adverse events and recalls
  • Label compliance, including a Drugs and Magic Remedies Act claim scanner

Supply Chain

  • Supplier qualification pipeline
  • WHO-GACP audit scoring
  • CITES lot guard
  • Forward and backward traceability from herb lot to distribution

Regulatory and Export

  • 125 Schedule T and WHO-GMP clauses with gap analysis
  • Mock inspection and Site Master File
  • Ayush Mark checklist
  • CoPP, EU THMPD, UK THR, US DSHEA and AYUSHEXCIL documents

Deviation and CAPA Management

Sources of Deviation

  • Manual entry
  • Yield variance
  • Schedule T gap
  • Supplier audit finding
  • Process-parameter excursion

Rule-Based Severity

  • Omitted Shodhana step
  • Bhasma test failure
  • Heavy-metal OOS result
  • These events are always classed as critical, with a seven-day due date

Investigation and Closure

  • 5-Why and fishbone analysis
  • CAPA with owners and due dates
  • Effectiveness verification
  • Closure with electronic signatures
Figure 6. Deviation and CAPA Workflow. Deviations are raised manually or automatically, classified by rules, and closed only after CAPA effectiveness is verified.

Comparison with Typical Approaches

CapabilityTypical ApproachAyush QMS
Batch recordsPrinted records of up to 50 pages; generic templates for tablets and liquidsTemplates and stage records for 12 kalpana types
Rasa ShastraNotebook records of purification and incinerationShodhana records signed by an authorised Vaidya or Hakim, with Bhasma logs and tests
QC specificationsCopied by hand from pharmacopoeia volumesDerived from seeded monographs and marker compounds
Schedule TConsultant checklists before an inspectionClauses mapped to records, with gap analysis and mock inspection
Audit trail and signaturesWet signatures and spreadsheetsAppend-only audit ledger with cryptographic verification and e-signatures
Export documentsDossiers assembled manually for each marketCoPP, EU THMPD, UK THR, US DSHEA and AYUSHEXCIL documents from batch data

Intended Users

Managing Director or Plant Head

Reviews inspection readiness and overall quality status.

Head of Quality Assurance

Manages Schedule T and WHO-GMP inspections, deviations and batch disposition.

QC Head and Analysts

Run test requests, OOS investigations and certificates of analysis.

Production Chemists and Operators

Complete batch records on the shop floor.

Vaidya or Hakim

Signs off classical formulations and Shodhana steps.

Regulatory Affairs

Prepares export dossiers and the Site Master File.

Data Integrity and Security

ControlImplementation
Audit trailGMP writes recorded in an append-only ledger with actor, role and before and after values, with Merkle-proof verification
Electronic signaturesDesigned to the pattern of US FDA 21 CFR Part 11, with re-authentication, stated meaning, four-eyes check and a linked audit transaction
Tenant isolationDatabase row-level security enforced on every tenant-scoped table
Segregation of dutiesRole-based access with AYUSH-specific roles; system administrators have no access to GMP records
Data integrityALCOA+ mapping, server-side timestamps, soft deletion only and retention enforcement

Scope and Current Coverage

The current compliance mapping covers Schedule T and WHO-GMP clauses. A conformance pack for the 2026 revision of Schedule T, including its labelling rules, is planned ahead of the 31 July 2029 date2. QC-approved release of raw-material lots, document and SOP control, change control, offline shop-floor capture, instrument integration, contract and loan-licence manufacturing, e-Aushadhi synchronisation and IQ, OQ and PQ validation documentation are also planned.

Frequently Asked Questions

Which manufacturers is Ayush QMS designed for?

Ayush QMS is designed for Ayurveda, Siddha and Unani drug manufacturers subject to Schedule T, with an initial focus on export-oriented units and units preparing for the revised Schedule T.

Does Ayush QMS support the revised Schedule T notified in 2026?

The current mapping covers Schedule T and WHO-GMP clauses. A dedicated conformance pack for the 2026 revision is planned ahead of the 31 July 2029 date for existing manufacturers.

Are the electronic signatures compliant with 21 CFR Part 11?

The signatures are designed to the pattern of 21 CFR Part 11, including re-authentication, stated meaning and a four-eyes check. Compliance for a given use depends on the manufacturer's own validation, and validation documentation is planned.

Does the system support classical Rasa Shastra processes?

Yes. Shodhana records with electronic signature, Bhasma preparation logs, puta cycles and Bhasma quality tests are included.

Which export documents can be prepared?

CoPP, EU THMPD, UK THR, US DSHEA and AYUSHEXCIL documents can be generated from batch data.

How does Ayush QMS relate to ComplyRx?

Ayush QMS is the quality system for AYUSH manufacturers. ComplyRx manages wider obligations such as labour, environment, export and corporate requirements, and an Ayush QMS customer can use ComplyRx for those obligations.

Request a Ayush QMS Demonstration

Aevum Digital can demonstrate a kalpana batch record, a Shodhana sign-off and a Schedule T gap analysis using sample data.

Contact Aevum Digital

References

  1. Ministry of Ayush, Ayush in India 2024. Source.
  2. Lexplosion, Drugs (Eleventh Amendment) Rules, 2026 for ASU drugs. Source.
  3. Corpseed, AYUSH Drugs (Eleventh Amendment) Rules, 2026 compliance requirements. Source.

Ayush QMS supports quality management. It does not guarantee inspection outcomes and does not replace professional regulatory advice. Regulatory information on this page was last reviewed on 1 November 2026 and is provided for general information.